Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Sickle-Cell Disease Patients' Attitudes Towards Their Treatment with Hydroxycarbamide

Frédéric Galactéros, MD PhD, Ersi Voskaridou, Anoosha Habibi, Giovanna Cannas, MD, Laure Joseph, MD, Stephanie Ngo, MD, Nathalie Lemonne, Emmanuelle Bernit, MD, Justine Gellen-Dautremer, MD, Gylna Loko, MD

Blood (2019) 134 (Supplement_1): 1013.

https://doi.org/10.1182/blood-2019-125673

Published: 2019

Journal Articles

Fetal Hemoglobin Measurement per Red Blood Cell Provides Biological and Clinical Protective Thresholds

Nicolas Hebert, Rakotoson Marie Georgine, PhD, Gwellaouen Bodivit, Etienne Audureau, MD PhD, Nadia Oubaya, Sadaf Pakdaman, Mehdi Sakka, Gaetana Di Liberto, PhD, Philippe Chadebech, PhD, Benoît Vingert, PhD, France Pirenne, MD PhD, Frédéric Galactéros, MD PhD, Marie Cambot, PhD, Pablo Bartolucci, MD PhD

Blood (2019) 134 (Supplement_1): 1008.

https://doi.org/10.1182/blood-2019-126727

Published: 2019

Journal Articles

Rituximab for Preventing Delayed Hemolytic Transfusion Reaction (DHTR) in Sickle CELL Adult Patients: Outcome of Transfusion and SIDE Effects in 58 CASES

Fabian Zanchetta-Balint, France Pirenne, MD PhD, Marc Michel, Armand Mekontso-Dessap, MD PhD, Matthieu Mahevas, MD, Constance Guillaud, MD, Keyvan Razazi, MD, Elena Foïs, MD, Frédéric Galactéros, MD PhD, Pablo Bartolucci, MD PhD, Anoosha Habibi

Blood (2019) 134 (Supplement_1): 3687.

https://doi.org/10.1182/blood-2019-130874

Published: 2019

Journal Articles

Long-Term Safety and Efficacy of Mitapivat (AG-348), a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency: The DRIVE PK Study

Rachael F. Grace, MD, D. Mark Layton, MB BS, FRCP, FRCPCH, Frédéric Galactéros, MD PhD, Wilma Barcellini, MD, Eduard J. van Beers, MD PhD, Hassan M. Yaish, MD, Yaddanapudi Ravindranath, MBBS, Kevin H. M. Kuo, MDMSc,FRCPC, Sujit Sheth, MD, Janet L. Kwiatkowski, MD MSCE, Lei Hua, PhD, Peter F. Hawkins, PhD, Chris Mix, MD, Bertil Glader, MD PhD

Blood (2019) 134 (Supplement_1): 3512.

https://doi.org/10.1182/blood-2019-123406

Published: 2019

Journal Articles

Outcomes of Pregnancies in Patients with Sickle-Cell Disease : Update from European Non-Interventional, Multicentric, Prospective Escort-HU Study

Frédéric Galactéros, MD PhD, Giovanna Cannas, MD, Pablo Bartolucci, MD PhD, Ersi Voskaridou, Laure Joseph, MD, Emmanuelle Bernit, MD, Justine Gellen-Dautremer, MD, Corinne Charneau, MD, Stephanie Ngo, MD, Anoosha Habibi

Blood (2019) 134 (Supplement_1): 891.

https://doi.org/10.1182/blood-2019-125812

Published: 2019

Journal Articles

Interest of a New Method for Free Plasma Heme Related Species Dosages in Sickle Cell Disease and Beta Thalassemia

Laurent Kiger, Sandia Adypagavane, Laura Bencheikh, PhD, Nicolas Hebert, Stephane Moutereau, MD, Frédéric Galactéros, MD PhD, Michael Marden, PhD, Yves Beuzard, MD, France Pirenne, MD PhD, Pablo Bartolucci, MD PhD

Blood (2019) 134 (Supplement_1): 3381.

https://doi.org/10.1182/blood-2019-130600

Published: 2019

Journal Articles

Causes of Death in 198 Sickle Cell Adult Patients: Old and New Trends

Anoosha Habibi, Stephanie Ngo, MD, Etienne Audureau, MD PhD, Armand Mekontso-Dessap, MD PhD, Keyvan Razazi, MD, Elena Foïs, MD, Thibaud Damy, MD PhD, France Pirenne, MD PhD, Marc Michel, Vincent Audard, MD PhD, Frédéric Galactéros, MD PhD, Pablo Bartolucci, MD PhD

Blood (2019) 134 (Supplement_1): 1031.

https://doi.org/10.1182/blood-2019-131304

Published: 2019

Journal Articles

GDF15 and Erythroferrone Mark Erythropoietic Response to ACE-011 (Sotatercept) in Thalassemia

Blood (2018) 132 (Supplement 1): 3633.

https://doi.org/10.1182/blood-2018-99-111770

Published: 2018

Journal Articles

Study of Metabolic Acidosis in Sickle Cell Disease Patients

Maud Cazenave, MD, Vincent Audard, MDPhD, Jean-Philippe Bertocchio, MDPhD, Anoosha Habibi, Caroline Bertoye, MD, Thomas Stehle, MD, Jugurtha Berkenou, Frédéric Galactéros, MD PhD, Pascal Houillier, Pablo Bartolucci, MD PhD, Marie Courbebaisse, MD PhD

Blood (2018) 132 (Supplement 1): 3667.

https://doi.org/10.1182/blood-2018-99-110235

Published: 2018

Journal Articles

Study of Dense Red Blood Cells in Children with Sickle Cell Disease

Basil Coulon, Gaetana Di Liberto, PhD, Orianne Wagner Ballon, Roberto Motterlini, Xavier Decrouy, Stephane Moutereau, Frederic Galacteros, MD PhD, France Pirenne, MD PhD, Pablo Bartolucci, MD PhD, Corinne Pondarré, MD PhD

Blood (2016) 128 (22): 4870.

https://doi.org/10.1182/blood.V128.22.4870.4870

Published: 2016

Journal Articles

Comparison of the Safety Profile of Sickle Cell Disease Patients Treated with Hydroxycarbamide in Off-Label Versus in-Label Prescriptions in the Escort-HU Non Interventional, Prospective, Observational Open-Label Cohort Study

Ersi Voskaridou, MD, Stephan Lobitz, MD, Uwe Kordes, MD MRCP, Regine Grosse, MD, Valentine Brousse, MD, Malika Benkerrou, MD, Mariane De Montalembert, MD PhD, Jean-Antoine Ribeil, MD PhD, Frederic Galacteros, MD PhD

Blood (2016) 128 (22): 2497.

https://doi.org/10.1182/blood.V128.22.2497.2497

Published: 2016

Journal Articles

Safety and Tolerability Of MP4CO: A Dose Escalation Study In Stable Patients With Sickle Cell Disease

Jo Howard, MB, BChir, MRCP, FRCPath, Swee Lay Thein, MBBS, DSc, Frederic Galacteros, MD PhD, Adlette Inati, MD, Marvin Reid, PhD, Peter E. Keipert, PhD, Tania N. Small, MD, Frank Booth, MA MSc BM BCh FACS

Blood (2013) 122 (21): 2205.

https://doi.org/10.1182/blood.V122.21.2205.2205

Published: 2013

Journal Articles

The Use Of Rituximab For Preventing Delayed Haemolytic Transfusion Reaction In Highly Immunized Patients With Sickle Cell Disease

France Noizat-Pirenne, MD-PhD, Marc Michel, IV, Armand Mekontso-Dessap, Constance Guillaud, Keyvan Razazi, Matthieu Mahévas, Sadaf Pakdaman, Frederic Galacteros, MD PhD, Pablo Bartolucci, MD, PhD, Anoosha Habibi, MD

Blood (2013) 122 (21): 1162.

https://doi.org/10.1182/blood.V122.21.1162.1162

Published: 2013

Journal Articles

A Phase 2a, Open-Label, Dose-Finding Study To Determine The Safety and Tolerability Of Sotatercept (ACE-011) In Adults With Beta (β)-Thalassemia: Interim Results

Maria-Domenica Cappellini, MD, John Porter, MD, Raffaella Origa, MD, Gian Luca Forni, MD, Adberrahmane Laadem, MD, Frédéric Galacteros, MD PhD, Dimana Miteva, PhD, Victoria Sung, PhD, Rajesh Chopra, MD, Jean-Benoît Arlet, MD, PhD, Jean-Antoine Ribeil, MD, PhD, Kenneth Klesczewski, PhD, Kenneth Attie, MD, Maciej Garbowski, MD, Olivier Hermine, MD, PhD

Blood (2013) 122 (21): 3448.

https://doi.org/10.1182/blood.V122.21.3448.3448

Published: 2013

Journal Articles

Biological Parameters Predictive Of Percent Dense Red Blood Cell Decrease Under Hydroxyurea Therapy

Marie Georgine Rakotoson, PhD student, Gaetana Di Liberto, PhD, Anoosha Habibi, MD, Christine Fauroux, Clinical Research Associate, Sanam Khorgami, Master Student, Dora Bachir, MD, France Noizat-Pirenne, MD-PhD, Frederic Galacteros, MD PhD, Pablo Bartolucci, MD-PhD

Blood (2013) 122 (21): 990.

https://doi.org/10.1182/blood.V122.21.990.990

Published: 2013

Journal Articles

Prospective Comparison of Sperm Parameters in SCD Adult Patients Before and after a 6 Months Treatment with hydroxyurea (HU)

Dora Bachir, MD, Francois Lionnet, Justine Gellen Dautremer, Katia Stankovic, Anoosha Habibi, Pablo Bartolucci, MD, PhD, Céline Chalas, Isabelle Berthaut, Florence Eustache, Célia Ravel, Jean Marie Kuntsman, Robert Girot, MD, Tabassome Simon, Jacqueline Mandelbaum, Frederic Galacteros, MD PhD

Blood (2012) 120 (21): 242.

https://doi.org/10.1182/blood.V120.21.242.242

Published: 2012

Journal Articles

French-Brazilian Survey On Pregnancy in Sickle Cell Disease A Study of the International Sickle Cell Disease Observatory

Blood (2012) 120 (21): 3215.

https://doi.org/10.1182/blood.V120.21.3215.3215

Published: 2012

Journal Articles

A Monocentric, Prospective, Observational Study On Vaso-Occlusive Crisis (VOC) in Adult Sickle-Cell Disease (SCD).

Pablo Bartolucci, MD, PhD, Anoosha Habibi, Mehdi Khellaf, Anne sophie Lascaux, Aline Santin, Françoise Roudot Thoraval, Stéphane Moutereau, Hélène Jouault, Yves Levy, MD, PhD, Bertrand Renaud, Frederic Galacteros, MD PhD, Bertrand Godeau, MD

Blood (2012) 120 (21): 2115.

https://doi.org/10.1182/blood.V120.21.2115.2115

Published: 2012

Journal Articles

A Somatic Mutation in the G6PD Gene in Hematopoietic Cells Causes a Chronic Haemolytic Anemia.

Loïc Garçon, Gérard Tertian, Audrey Boutron, Françoise Driss, Stéphane Giraudier, William Vainchenker, MD, PhD, Michel Goossens, MD, Frederic Galacteros, MD, PhD, Gil Tchernia, MD, Claude Préhu

Blood (2009) 114 (22): 4033.

https://doi.org/10.1182/blood.V114.22.4033.4033

Published: 2009

Journal Articles

Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease Patients: Evidence of An Emerging Syndrome with Suicidal Erythrocyte Death

France Noizat-Pirenne, MD, PhD, Philippe Chadebech, PhD, Anoosha Habibi, MD, Dora Bachir, MD, Ruben Nzouakou, MD, Frederic Galacteros, MD, PhD, Philippe Bierling, MD, PhD

Blood (2008) 112 (11): 3037.

https://doi.org/10.1182/blood.V112.11.3037.3037

Published: 2008

NARROW

Sickle-Cell Disease Patients' Attitudes Towards Their Treatment with Hydroxycarbamide

Fetal Hemoglobin Measurement per Red Blood Cell Provides Biological and Clinical Protective Thresholds

Rituximab for Preventing Delayed Hemolytic Transfusion Reaction (DHTR) in Sickle CELL Adult Patients: Outcome of Transfusion and SIDE Effects in 58 CASES

Long-Term Safety and Efficacy of Mitapivat (AG-348), a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency: The DRIVE PK Study

Outcomes of Pregnancies in Patients with Sickle-Cell Disease : Update from European Non-Interventional, Multicentric, Prospective Escort-HU Study

Interest of a New Method for Free Plasma Heme Related Species Dosages in Sickle Cell Disease and Beta Thalassemia

Causes of Death in 198 Sickle Cell Adult Patients: Old and New Trends

GDF15 and Erythroferrone Mark Erythropoietic Response to ACE-011 (Sotatercept) in Thalassemia

Study of Metabolic Acidosis in Sickle Cell Disease Patients

Study of Dense Red Blood Cells in Children with Sickle Cell Disease

Comparison of the Safety Profile of Sickle Cell Disease Patients Treated with Hydroxycarbamide in Off-Label Versus in-Label Prescriptions in the Escort-HU Non Interventional, Prospective, Observational Open-Label Cohort Study

Safety and Tolerability Of MP4CO: A Dose Escalation Study In Stable Patients With Sickle Cell Disease

The Use Of Rituximab For Preventing Delayed Haemolytic Transfusion Reaction In Highly Immunized Patients With Sickle Cell Disease

A Phase 2a, Open-Label, Dose-Finding Study To Determine The Safety and Tolerability Of Sotatercept (ACE-011) In Adults With Beta (β)-Thalassemia: Interim Results

Biological Parameters Predictive Of Percent Dense Red Blood Cell Decrease Under Hydroxyurea Therapy

Prospective Comparison of Sperm Parameters in SCD Adult Patients Before and after a 6 Months Treatment with hydroxyurea (HU)

French-Brazilian Survey On Pregnancy in Sickle Cell Disease A Study of the International Sickle Cell Disease Observatory

A Monocentric, Prospective, Observational Study On Vaso-Occlusive Crisis (VOC) in Adult Sickle-Cell Disease (SCD).

A Somatic Mutation in the G6PD Gene in Hematopoietic Cells Causes a Chronic Haemolytic Anemia.

Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease Patients: Evidence of An Emerging Syndrome with Suicidal Erythrocyte Death

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only